CBX3/HP1γ expression as measured in those assays was associated with malignant clinicopathological characteristics, such as AFP > 20 μg/L, liver cirrhosis, tumor size > 5 cm, multiple tumors, vascular invasion, and tumor recurrence. This evidence concerns the gene AFP and neoplasm.